Globus Medical (GMED) PT Raised to $65 at Piper Jaffray
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Price: $79.58 --0%
Rating Summary:
22 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Rating Summary:
22 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Join SI Premium – FREE
Piper Jaffray analyst Matt O'Brien raised the price target on Globus Medical (NYSE: GMED) to $65.00 (from $62.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Globus Medical acquires Synaptive Medical in cranial neurosurgery deal
- Sportradar Group AG (SRAD) PT Lowered to $12 at JPMorgan
- Versant Media Group (VSNT) PT Lowered to $39 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
